Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T06:56:04.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows a minor update to the study protocol/document version from v3.4.1 to v3.4.2, with no visible changes to study information.
    Difference
    0.1%
    Check dated 2026-02-13T12:51:42.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site revision updated from v3.4.0 to v3.4.1; no changes to study details, eligibility criteria, or results are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:24:20.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI elements for showing/hiding a glossary were added, and several page metadata labels related to results posting and QC criteria were updated (including Revision: v3.4.0). Some legacy labels such as 'Estimated' for results timing and 'No FEAR Act data' entries were removed.
    Difference
    0.4%
    Check dated 2026-01-22T18:15:00.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. This change is limited to metadata and does not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T13:24:04.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing California, New York, and Texas (v3.3.3) and removed the prior state-location pages; the HHS Vulnerability Disclosure link was removed (v3.3.2).
    Difference
    0.4%
    Check dated 2025-12-17T21:57:43.000Z thumbnail image

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.